AMGEN INC - 8-K Filing
Amgen Inc. held its annual meeting on May 19, 2026, where shareholders elected all 12 director nominees with votes ranging from 390 million to 409 million in favor. Shareholders also approved the advisory vote for executive compensation (399 million for) and ratified Ernst & Young LLP as independent auditors (447 million for). A stockholder proposal requiring an independent board chairman was rejected, receiving only 72.9 million votes in favor versus 338.5 million against. (Items: 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $AMGN